The Medtronic Harmony Transcatheter Pulmonary Valve (TPV) System. It is first in the world non-surgical heart valve to treat pediatric and adult patients with a native or surgically-repaired right ventricular outflow tract (RVOT) to stop severe pulmonary valve regurgitation caused by congenital heart disease.
Feature | Structural Heart | By Dave Fornell, Editor
FDA Clears First Device to Treat Right Ventricular Outflow Tract Congenital Heart Disease

March 26, 2021 — Today, the U.S. Food and Drug Administration (FDA) cleared the Medtronic Harmony Transcatheter ...

Home March 26, 2021
Home
The March April 2021 issue of DAIC, Diagnostic and Interventional Cardiology magazine, Dave Fornell is the editor.
Feature
The DAIC March-April 2021 Digital Edition

View the March-April 2021 digital edition of Diagnostic and Interventional Cardiology (DAIC) magazine, including links ...

Home March 26, 2021
Home
Virtual tour views of a University of Colorado cath lab during a CTO procedure (top left), the new robotic EP lab at Banner Health (top right), a bi-plane EP/cath combo lab at Baylor Heart Hospital Dallas (bottom left, and an ECMO procedure at Tufts Medical Center cath lab. Photos by Dave Fornell
Feature
Virtual Tours of Cath and EP Labs

There is a lot of interest in how other hospitals organize and equip their cardiac cath labs and electrophysiology (EP) ...

Home March 25, 2021
Home
Neonates and young pediatric patients with congenital heart disease have few options for implantable electrophysiology (EP) devices like pacemakers or ICDs.
News | Congenital Heart
Critical Need for Pediatric Electrophysiology Devices is Focus of Medical Device Competition 

March 24, 2021 — Congenital heart disease (CHD) affects six out of 1,000 babies born in the U.S. each year and is often ...

Home March 24, 2021
Home
PA pressure-guided heart failure management is fast becoming the standard of care in NYHA Class III patients. The Cordella Pulmonary Artery Pressure Sensor enables clinicians to remotely monitor and proactively adjust therapy and medications remotely without the need for office visits.
News | Heart Failure
100th Patient Implanted With Cordella Pulmonary Artery Pressure Sensor For Proactive, Remote Heart Failure Management

March 24, 2021 — Endotronix Inc., a digital health and medical technology company working on advancements in treating of ...

Home March 24, 2021
Home
Videos | Structural Heart
VIDEO: PFO Closure Shows Continued Stroke Prevention Benefit at 5 Years

Interview with Scott E. Kasner, M.D., who served as the principle investigator for the Gore Cardioform REDUCE trial, and ...

Home March 23, 2021
Home
Top left, electromechanical wave imaging (EWI) isochrone renderings showing the activation points of the myocardium based on echocardiography axial strain measurements. Bottom right, EWI images overlaid on patient's CT scan of the heart.
News | EP Lab
New Ultrasound Technique Helps Pinpoint Source of Arrhythmias

March 23, 2021 — Researchers at Columbia University are using cardiac ultrasound to improve the critical need to ...

Home March 23, 2021
Home
Early detection of high-risk plaque phenotypes holds the promise to prevent myocardial infarction and ischemic stroke by enabling personalized therapeutics. The company Elucid has developed AI to identify these atherosclerotic plaque phenotypes from a CT scan.
News | CT Angiography (CTA)
Study Demonstrates AI Can Estimate RNA Expression From Cardiac CT Scan

March 23, 2021 — Researchers at the Karolinska Institute in Stockholm, Sweden, have published the first-of-its-kind ...

Home March 23, 2021
Home
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) can potentiate all 3 sides of Virchow’s Triad of coagulopathy, including endothelial dysfunction, blood flow stasis, and hypercoagulability. Angiotensin-converting enzyme-2 (ACE-2)–dependent viral entry and the virus-induced inflammatory response can lead to endothelial dysfunction. Clotting Prevention in COVID-19 Patients, Thrombosis Prevention in COVID-19 Patients, Preventing blood clots in COVID-19 patients
Feature | Antiplatelet and Anticoagulation Therapies | By Dave Fornell, Editor
Overview of Trials for Anticoagulation Therapy for COVID-19 Patients

A comprehensive review or more than 80 randomized controlled trials (RCTs) investigating how to best manage optimal ...

Home March 22, 2021
Home
Videos | Ventricular Assist Devices (VAD)
VIDEO: New LVAD Designed to Prevent Hemolysis and Clots

Surgeons at Penn State Heart and Vascular Institute were the second group in the nation to implant a newly-designed ...

Home March 22, 2021
Home
University of Minnesota researchers used a hybrid of tissue engineering and regenerative medicine to create heart valves that can grow with the recipient. When implanted in lambs, researchers showed that the tri-tube valves worked better than current animal-derived valves with almost none of the calcification or blood clotting that the other valves showed. This can be implanted in pediatric patients with congenital heart diseas. Photo from Syedain, et al., Tranquillo Lab, University of Minnesota
News | Heart Valve Technology
Lab-created Heart Valves Can Grow With the Patient

March 18, 2020 — A groundbreaking new study led by University of Minnesota Twin Cities researchers from both the College ...

Home March 18, 2021
Home
Vscan Air, a pocket-sized ultrasound from GE Healthcare, enters the market as one of the smallest and lightweight handheld devices without compromising crystal clear image quality and secure data sharing. The vScan is a point of care ultrasound (POCUS).
News | Point-of-Care Ultrasound (POCUS)
GE Healthcare Unveils Vscan Air Wireless Handheld Ultrasound

March 18, 2021 — GE Healthcare this week unveiled Vscan Air, a cutting-edge, wireless pocket-sized ultrasound that ...

Home March 18, 2021
Home
Boston Scientific's TheraSphere Y-90 Glass Microspheres enable selective internal radiation therapy (SIRT), or radioembolization, for hepatocellular carcinoma. This treats liver cancer with low toxicity using millions of microscopic glass beads containing radioactive yttrium (Y-90), delivered directly to liver tumors via catheter. The result in minimal radiation exposure to surrounding healthy tissue.
News | Interventional Radiology
FDA Clears Boston Scientific TheraSphere Y-90 Transcatheter Liver Embolization Microspheres

March 18, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's TheraSphere Y-90 Glass ...

Home March 18, 2021
Home
Integrating data from an array of implantable EP devices from different vendors can be difficult or require disconnected silos of data for different vendors. One solution that was recently introduced to integrate data from various vendors is the Optimize EP software, which allows viewing data from all device vendors in one platform to streamline workflows.
Feature | EP Lab | By Maninder Bedi, M.D.
The Future of Remote Monitoring is Streamlining of Cardiac Device Data Management

A few weeks ago, a patient of mine experienced a cardiac event — his heart stopped. Completely. However, his implantable ...

Home March 17, 2021
Home
MRI scan of a damaged heart. Blue means reduced blood flow, orange is good blood flow. In this figure the inferior part of the heart shows dark blue, so the myocardial blood flow is very reduced. The angiogram shows the coronary artery which supplies the blood to this part of the heart is occluded. The three colored MRI images show different slices of the heart — the basal mid and apical slices. Image courtesy of European Heart Journal #COVID #COVID19
News | Coronavirus (COVID-19)
Heart Damage Found in More Than Half of COVID-19 Patients Discharged From Hospitals

March 17, 2021 — Around 50% of patients who have been hospitalized with severe COVID-19 (SARS-CoV-2) and have damage to ...

Home March 17, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now